Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations

Fluoroquinolone (FQ) antibiotics have been shown to reduce mortality and the number of febrile episodes when used as prophylaxis during neutropenia. Prior studies suggest that prophylaxis may result in increasing rates of FQ resistance. Fluoroquinolone non-susceptibility trends in Escherichia coli i...

Full description

Bibliographic Details
Main Authors: Christopher G. Hauck, Pearlie P. Chong, Melissa B. Miller, Katarzyna Jamieson, Jason P. Fine, Matthew C. Foster, Thomas C. Shea, David van Duin
Format: Article
Language:English
Published: Case Western Reserve University 2016-09-01
Series:Pathogens and Immunity
Subjects:
Online Access:https://paijournal.com/index.php/paijournal/article/view/115
_version_ 1811326789115445248
author Christopher G. Hauck
Pearlie P. Chong
Melissa B. Miller
Katarzyna Jamieson
Jason P. Fine
Matthew C. Foster
Thomas C. Shea
David van Duin
author_facet Christopher G. Hauck
Pearlie P. Chong
Melissa B. Miller
Katarzyna Jamieson
Jason P. Fine
Matthew C. Foster
Thomas C. Shea
David van Duin
author_sort Christopher G. Hauck
collection DOAJ
description Fluoroquinolone (FQ) antibiotics have been shown to reduce mortality and the number of febrile episodes when used as prophylaxis during neutropenia. Prior studies suggest that prophylaxis may result in increasing rates of FQ resistance. Fluoroquinolone non-susceptibility trends in Escherichia coli isolated from blood and urine cultures were evaluated over a 16-year period during which prophylaxis was initiated in patients with hematologic malignancies and stem cell transplants. Non-susceptibility rates increased after the introduction of prophylaxis, with yearly non-susceptibility rates rising from 30%­–33% to 40%–88% in blood isolates. The high rates of non-susceptibility now observed raise concerns about the continued efficacy of FQ prophylaxis. This concern exists particularly in those patients undergoing stem cell transplants where the total FQ non-susceptibility rates over the study period were 82.3%. Further evaluation of the effect of FQ prophylaxis on antibiotic resistance and its efficacy in the setting of increased rates of resistance is warranted.
first_indexed 2024-04-13T14:55:36Z
format Article
id doaj.art-cee5a856a4c34b67b6cff333ac68de55
institution Directory Open Access Journal
issn 2469-2964
language English
last_indexed 2024-04-13T14:55:36Z
publishDate 2016-09-01
publisher Case Western Reserve University
record_format Article
series Pathogens and Immunity
spelling doaj.art-cee5a856a4c34b67b6cff333ac68de552022-12-22T02:42:27ZengCase Western Reserve UniversityPathogens and Immunity2469-29642016-09-011223424210.20411/pai.v1i2.11527Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy PopulationsChristopher G. Hauck0Pearlie P. Chong1Melissa B. Miller2Katarzyna Jamieson3Jason P. Fine4Matthew C. Foster5Thomas C. Shea6David van Duin7Division of Infectious Diseases, University of North Carolina, Chapel Hill, NCDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NCDepartment of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NCDivision of Hematology/Oncology, University of North Carolina, Chapel Hill, NCBiostatistics Department, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NCDivision of Hematology/Oncology, University of North Carolina, Chapel Hill, NCDivision of Hematology/Oncology, University of North Carolina, Chapel Hill, NCDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NCFluoroquinolone (FQ) antibiotics have been shown to reduce mortality and the number of febrile episodes when used as prophylaxis during neutropenia. Prior studies suggest that prophylaxis may result in increasing rates of FQ resistance. Fluoroquinolone non-susceptibility trends in Escherichia coli isolated from blood and urine cultures were evaluated over a 16-year period during which prophylaxis was initiated in patients with hematologic malignancies and stem cell transplants. Non-susceptibility rates increased after the introduction of prophylaxis, with yearly non-susceptibility rates rising from 30%­–33% to 40%–88% in blood isolates. The high rates of non-susceptibility now observed raise concerns about the continued efficacy of FQ prophylaxis. This concern exists particularly in those patients undergoing stem cell transplants where the total FQ non-susceptibility rates over the study period were 82.3%. Further evaluation of the effect of FQ prophylaxis on antibiotic resistance and its efficacy in the setting of increased rates of resistance is warranted.https://paijournal.com/index.php/paijournal/article/view/115Fluoroquinolone resistanceEscherichia colistem cell transplanthematologic malignancy
spellingShingle Christopher G. Hauck
Pearlie P. Chong
Melissa B. Miller
Katarzyna Jamieson
Jason P. Fine
Matthew C. Foster
Thomas C. Shea
David van Duin
Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
Pathogens and Immunity
Fluoroquinolone resistance
Escherichia coli
stem cell transplant
hematologic malignancy
title Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
title_full Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
title_fullStr Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
title_full_unstemmed Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
title_short Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
title_sort increasing rates of fluoroquinolone resistance in escherichia coli blood and urinary isolates in stem cell transplant and hematologic malignancy populations
topic Fluoroquinolone resistance
Escherichia coli
stem cell transplant
hematologic malignancy
url https://paijournal.com/index.php/paijournal/article/view/115
work_keys_str_mv AT christopherghauck increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT pearliepchong increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT melissabmiller increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT katarzynajamieson increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT jasonpfine increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT matthewcfoster increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT thomascshea increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations
AT davidvanduin increasingratesoffluoroquinoloneresistanceinescherichiacolibloodandurinaryisolatesinstemcelltransplantandhematologicmalignancypopulations